Stay updated on Ampyra Optic Neuritis in MS Clinical Trial
Sign up to get notified when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.

Latest updates to the Ampyra Optic Neuritis in MS Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4 in the page footer, indicating a software update to the ClinicalTrials.gov interface. This change does not modify any study content or results.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe site's revision label was updated from v3.6.0 to v3.6.3, indicating a platform update. This update does not alter the study details or other user-facing content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows 'No longer looking for participants,' indicating recruitment has closed, and new help/navigation sections such as 'How to Read a Study Record,' 'Common Questions,' and 'How to Join a Study' have been added. The 'Intervention/Treatment' heading formatting has been updated and the revision version has been bumped from v3.5.5 to v3.6.0.SummaryDifference0.4%

- Check62 days agoChange DetectedThe page now shows Revision: v3.5.5 in the footer, replacing the previous Revision: v3.5.4. This indicates a minor version update for the page or site content without altering the study details.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page revision tag was updated to v3.5.4, indicating a new revision of the page content. This likely reflects minor content or formatting updates since the previous version.SummaryDifference0.1%

- Check105 days agoChange DetectedThis updates the page’s displayed revision version from v3.5.0 to v3.5.3, reflecting a site/version change rather than a modification to the study information.SummaryDifference0.1%

Stay in the know with updates to Ampyra Optic Neuritis in MS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ampyra Optic Neuritis in MS Clinical Trial page.